|
1. Biologie
|
|
|
|
1.4 Biologie - Technos
|
|
|
|
|
|
|
|
|
|
|
|
5. Traitements
|
|
|
|
5.1 Traitements - Pré-clinique
|
|
|
|
5.12 Immunothérapies
|
|
|
|
5.12.1 Immunothérapies - partenariats
|
|
|
Incyte pays MacroGenics $150M for PD-1 inhibitor [FierceBiotech]
|
|
|
|
|
|
Incyte
is already testing its IDO1 inhibitor epacadostat in combination with
checkpoint inhibitors from Merck and Bristol-Myers Squibb. Going
forward, it will be able to develop and sell its drugs together with
MGA012, provided it matches up to competitors already on the market.
That isn’t a certainty, a fact Incyte has already learned the hard way.
|
|
|
|
|
|
|
5.12.2 Immunothérapies - CAR-T
|
|
|
|
5.2 Pharma
|
|
|
|
5.3 Traitements - FDA, EMA, NICE...
|
|
|
|
6. Lutte contre les cancers
|
|
|
|
|
6.1 Observation
|
|
|
|
|
|
6.10.1 Politiques (USA)
|
|
|
|
6.6 Publications
|
|
|
|
|
6.9 Controverses
|
|
|